Qing has more than 20 years of executive leadership and board service for corporations in the U.S. and China, serving some key industries: automotive, biotech / pharma / healthcare, education, and public accounting. Having served as
• key members of two start-up companies’ leadership team in China and the US, respectively
• one of the leaders of the International Market Legal Entity rationalization and integration for the Bristol Myers Squibb (BMS) – Celgene $75 billion acquisition,
• the Head of Finance and Administration of BMS China/Hong Kong leading the launch of the first immune-oncology cancer drug in China and establishment of new distribution channels, and product life cycle planning and management for mature brands,
• the General Manager and CFO of one of General Motor’s (GM’s) China joint ventures,
• finance leader of multiple deals, brand / product exiting, restructuring, and ERP system, process and control design and implementation,
• lead auditor supporting various clients’ equity and debt offerings, internal control / SOX readiness, and SEC filings,
Qing is accustomed to the rigors of fast-paced, highly regulated environments requiring sharp diligence, accuracy, and outstanding communication skills. Qing is passionate with commitment to serve. She has a track record of successful interacting, communicating, and negotiating with Chinese partners and various government agencies. Qing is also a champion of change with an ability to develop innovative and creative solutions.

During her 13 years in China, Qing also served a range of non-profit organizations:
• Board of Governors of American Chamber of Commerce, Shanghai
• Board member of ATHENA International (USA)
• VP and Board of Director of IPWS (International Professional Women’s Society), a women’s organization in APAC
• Mentor for Mentor Walks in Asia
• Mentor of World Academy for the Future of Women (WAFW)